PMID- 26712731 OWN - NLM STAT- MEDLINE DCOM- 20161006 LR - 20201209 IS - 1420-3049 (Electronic) IS - 1420-3049 (Linking) VI - 21 IP - 1 DP - 2015 Dec 25 TI - A Herbal Formula, Atofreellage, Ameliorates Atopic Dermatitis-Like Skin Lesions in an NC/Nga Mouse Model. PG - E35 LID - 10.3390/molecules21010035 [doi] LID - 35 AB - We evaluated the anti-atopic dermatitis (AD) effect of Atofreellage (AF), a herbal formula composed of 10 medicinal plants. AD was induced on the dorsal skin areas of NC/Nga mice (male, seven weeks old) by daily application of 2,4-dinitrochlorobenzene (DNCB) for five weeks. After three weeks of DNCB application, 200 muL of AF (0, 25, 50 or 100 mg/mL) was applied to the skin lesions. Histological findings, blood cell populations, serum levels of immunoglobulin E (IgE), histamine, pro-inflammatory cytokines, and inflammatory signaling in the skin tissue, and T-helper cell type 2 (Th(2))-related cytokines in splenocytes were analyzed. Histopathological findings showed AF treatment notably attenuated the thickness of dorsal skin, and eosinophil infiltration. AF treatment (especially 100 mg/mL) also demonstrably ameliorated the blood cell population abnormalities, as the notable elevation of serum concentrations of IgE, histamine, TNF-alpha, IL-6 and IL-1beta were remarkably normalized by AF treatment. Western blot analysis evidenced the apparent normalization of inflammatory signals (ERK, p38 MAP kinase, JNK, and NF-kappaB) in the skin tissue. Additionally, AF treatment notably attenuated the activation of Th(2)-dominant cytokines (IL-13, IL-4, and IL-5) in Con A-treated splenocytes in an ex vivo assay. In conclusion, this study provides experimental evidence for the clinical relevance of Atofreellage. FAU - Kim, Won-Yong AU - Kim WY AD - Liver and Immunology Research-Center, Daejeon Oriental Hospital of Daejeon University, 176-9, Daeheung-ro, Jung-Gu, Daejeon 34929, Korea. godunga3@naver.com. FAU - Kim, Hyeong-Geug AU - Kim HG AD - Liver and Immunology Research-Center, Daejeon Oriental Hospital of Daejeon University, 176-9, Daeheung-ro, Jung-Gu, Daejeon 34929, Korea. winakim@dju.kr. FAU - Lee, Hye-Won AU - Lee HW AD - TKM-Based Herbal Drug Research Group, Korea Institute of Oriental Medicine, Daejeon 34054, Korea. hwlee@kiom.re.kr. FAU - Lee, Jin-Seok AU - Lee JS AD - Liver and Immunology Research-Center, Daejeon Oriental Hospital of Daejeon University, 176-9, Daeheung-ro, Jung-Gu, Daejeon 34929, Korea. neptune26ljs@naver.com. FAU - Im, Hwi-Jin AU - Im HJ AD - Liver and Immunology Research-Center, Daejeon Oriental Hospital of Daejeon University, 176-9, Daeheung-ro, Jung-Gu, Daejeon 34929, Korea. lastdohee@gmail.com. FAU - Kim, Hyo-Seon AU - Kim HS AD - Liver and Immunology Research-Center, Daejeon Oriental Hospital of Daejeon University, 176-9, Daeheung-ro, Jung-Gu, Daejeon 34929, Korea. khs910707@hanmail.net. FAU - Lee, Sung-Bae AU - Lee SB AD - Liver and Immunology Research-Center, Daejeon Oriental Hospital of Daejeon University, 176-9, Daeheung-ro, Jung-Gu, Daejeon 34929, Korea. sky161300@naver.com. FAU - Son, Chang-Gue AU - Son CG AD - Liver and Immunology Research-Center, Daejeon Oriental Hospital of Daejeon University, 176-9, Daeheung-ro, Jung-Gu, Daejeon 34929, Korea. ckson@dju.ac.kr. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20151225 PL - Switzerland TA - Molecules JT - Molecules (Basel, Switzerland) JID - 100964009 RN - 0 (Cytokines) RN - 0 (Dinitrochlorobenzene) RN - 0 (Plant Extracts) RN - 37341-29-0 (Immunoglobulin E) RN - 820484N8I3 (Histamine) SB - IM MH - Animals MH - Cytokines/metabolism MH - Dermatitis, Atopic/chemically induced/*drug therapy/*immunology MH - Dinitrochlorobenzene/adverse effects MH - Disease Models, Animal MH - Histamine/metabolism MH - Immunoglobulin E/metabolism MH - MAP Kinase Signaling System/drug effects MH - Male MH - Mice MH - Plant Extracts/*administration & dosage/chemistry/pharmacology MH - Spleen/*drug effects/immunology MH - Th2 Cells/metabolism PMC - PMC6273903 OTO - NOTNLM OT - NC/Nga murine model OT - atopic dermatitis OT - herbal medicine OT - inflammation COIS- The authors declare no conflict of interest. EDAT- 2015/12/30 06:00 MHDA- 2016/10/08 06:00 PMCR- 2015/12/25 CRDT- 2015/12/30 06:00 PHST- 2015/11/07 00:00 [received] PHST- 2015/12/18 00:00 [revised] PHST- 2015/12/21 00:00 [accepted] PHST- 2015/12/30 06:00 [entrez] PHST- 2015/12/30 06:00 [pubmed] PHST- 2016/10/08 06:00 [medline] PHST- 2015/12/25 00:00 [pmc-release] AID - molecules21010035 [pii] AID - molecules-21-00035 [pii] AID - 10.3390/molecules21010035 [doi] PST - epublish SO - Molecules. 2015 Dec 25;21(1):E35. doi: 10.3390/molecules21010035.